Statistiche di base
| CIK | 1472072 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| August 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| July 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| July 14, 2025 |
Exhibit 99.1 Concord Healthcare Announces Completion of China’s First Proton Therapy for Choroidal Malignant Melanoma BEIJING, July 14, 2025 /PRNewswire/ - Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE |
|
| July 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| June 25, 2025 |
6-K 1 tm2518913d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang Dis |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| June 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Rep |
|
| May 29, 2025 |
Concord Healthcare Announces Official Release of the Proton Therapy Large Model Exhibit 99.1 Concord Healthcare Announces Official Release of the Proton Therapy Large Model BEIJING, May 29, 2025 /PRNewswire/ - Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 24 |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Rep |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Rep |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Rep |
|
| April 25, 2025 |
Consent of Shandong Haoxin Certified Public Accountants Co., Ltd. Exhibit 15.1 Consent of Shandong Haoxin Certified Public Accountants Co., Ltd. We hereby consent to the incorporation by reference in this Annual Report on Form 20-F of Concord Medical Services Holdings Limited of our report dated April 25, 2025 relating to the financial statements, which appears in this Form 20-F. Shandong Haoxin Certified Public Accountants Co., Ltd. /s/ Shandong Haoxin Certifie |
|
| April 25, 2025 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jianyu Yang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| April 25, 2025 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wei Jiang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 25, 2025 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of t |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| April 25, 2025 |
Exhibit 15.2 34/F, Tower 3, China Central Place, 77 Jianguo Road, Beijing 100025, China Telephone: (86-10) 5809-1000 Facsimile: (86-10) 5809-1100 April 25, 2025 Concord Medical Services Holdings Limited Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China Dear Sirs: We have acted as legal advisor as to the laws of the People’s R |
|
| April 25, 2025 |
Exhibit 13.2 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wei Jiang, Chief Financial Officer of the |
|
| April 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| April 11, 2025 |
Concord Medical Announces Changes Exhibit 99.1 Concord Medical Announces Changes in Management BEIJING, April 11, 2025 - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced changes in its management. Changes in Management Appointment of New Chief Financial Officer and New Chief |
|
| January 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s |
|
| January 6, 2025 |
Concord Medical Announces Result of 2024 Annual General Meeting Exhibit 99.1 Concord Medical Announces Result of 2024 Annual General Meeting BEIJING, January 6, 2025 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it held its 2024 annual general meeting of shareholders on December 27 |
|
| December 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’ |
|
| December 9, 2024 |
Exhibit 99.1 Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate BEIJING, December 9, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that the Nation |
|
| November 13, 2024 |
Concord Medical Schedules 2024 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2024 Annual Meeting of Shareholders BEIJING, November 13, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it will hold its 2024 annual general meeting of shareholders (the “Mee |
|
| November 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’ |
|
| November 13, 2024 |
Concord Medical Services Holdings Limited (the "Company") FORM OF PROXY FOR SHAREHOLDERS Exhibit 99.3 Concord Medical Services Holdings Limited (the "Company") FORM OF PROXY FOR SHAREHOLDERS I/We (name) of (address) being the holder of (number) Class A ordinary shares and (number) Class B ordinary shares in the Company hereby appoint (name) of ) (address) or failing him/her (name) of ) (address) or failing him/her, the duly appointed Chairman of the Meeting (the "Chairman") as my/our |
|
| November 13, 2024 |
Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") Notice of Annual General Meeting of the Company Notice is hereby given that an Annual General Meeting of the Company (the "Meeting") will be held at the offices of Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, People's Republic of China at 10:00 A.M. (Beijing time), on December 27 |
|
| November 13, 2024 |
Exhibit 99.4 Proof 1 5-Nov-24 The Board of Directors unanimously recommends a vote FOR the Resolution. Resolution FOR AGAINST ABSTAIN Res. 1 Concord Medical Services Holdings Limited TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS REPRESENTING ORDINARY SHARES OF Concord Medical Services Holdings Limited Sign below Date: Please sign this Voting Instruction Card exactly as your name(s) app |
|
| September 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People |
|
| September 27, 2024 |
Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets (in thousands) Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2024 BEIJING, September 27, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months end |
|
| September 16, 2024 |
Exhibit 99.1 Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment BEIJING, September 16, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Guangzhou Concord |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People |
|
| August 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s |
|
| August 7, 2024 |
Concord Medical Regains Compliance with NYSE Minimum Price Requirement Exhibit 99.1 Concord Medical Regains Compliance with NYSE Minimum Price Requirement BEIJING, August 7, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter from the New York Stock Exchange (“NYSE |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Re |
|
| July 11, 2024 |
J.P.Morgan J.P.Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 2 (d) Beneficial Owner 2 (e) Commission 2 (f) Custodian 2 (g) Deliver, execute, issue et al. 2 (h) Delivery Order 2 (i) Deposited Securities 2 (j) Direct Registration System 3 (k) Holder 3 (l) Removal Notice Date 3 (m) Resignation Notice D |
|
| July 11, 2024 |
Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Concord Medical Services Holdings Limited, 333-163559) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate t |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| July 11, 2024 |
As filed with the U.S. Securities and Exchange Commission on July 11, 2024 As filed with the U.S. Securities and Exchange Commission on July 11, 2024 Registration No. 333-163559 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ForAmerican Depositary Shares Evidenced by American Depositary Receipts Concord Medical Services Holdings Limited (Exact name of issuer of d |
|
| July 11, 2024 |
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE Exhibit 99.1 CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE BEIJING, July 11, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it plans to change the ratio of its American depositary shares (“ADSs”) to |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| April 19, 2024 |
Exhibit 11.2 EXHIBIT A CONCORD MEDICAL SERVICES HOLDINGS LIMITED STATEMENT OF POLICIES GOVERNING MATERIAL, NON-PUBLIC INFORMATION AND THE PREVENTION OF INSIDER TRADING Adopted on November 17, 2009 and effective conditional and immediately upon commencement of the trading of the American depositary shares (the “ADSs”) of Concord Medical Services Holdings Limited (the “Company”) representing ordinar |
|
| April 19, 2024 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jianyu Yang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| April 19, 2024 |
Exhibit 97.1 Concord Medical Services Holdings Limited COMPENSATION RECOVERY POLICY As adopted on November 29, 2023 Concord Medical Services Holdings Limited (the “Company”) is committed to strong corporate governance. As part of this commitment, the Company’s board of directors (the “Board”) has adopted this clawback policy called the Compensation Recovery Policy (the “Policy”). The Policy is int |
|
| April 19, 2024 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Boxun Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| April 19, 2024 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Boxun Zhang, Chief Financial Officer of t |
|
| April 19, 2024 |
CONSENT OF Independent Registered Public Accounting Firm Exhibit 15.1 CONSENT OF Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 19, 2024, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited incl |
|
| April 19, 2024 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of t |
|
| April 19, 2024 |
Exhibit 15.2 34/F, Tower 3, China Central Place, 77 Jianguo Road, Beijing 100025, China Telephone: (86-10) 5809-1000 Facsimile: (86-10) 5809-1100 April 19, 2024 Concord Medical Services Holdings Limited Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China Dear Sirs: We have acted as legal advisor as to the laws of the People’s R |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s R |
|
| February 20, 2024 |
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price Exhibit 99.1 Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price BEIJING, February 20, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the “Letter”) |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 10 |
|
| January 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 26A1-26A5, East Tower, Hanwei Building No. 7 Guanghua Road, Chaoyang District Beijing 100013 People |
|
| January 9, 2024 |
Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited Exhibit 99.1 Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited BEIJING, January 9, 2024 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced the listing of a minority stake of 39,420,20 |
|
| November 20, 2023 |
Concord Medical Services Holdings Limited (the “Company”) Exhibit 99.3 Concord Medical Services Holdings Limited (the “Company”) PROXY I/We* (name) of (address), the holder of (number) Class A ordinary shares and (number) Class B ordinary shares in the Company, hereby appoint (name) of (address) and/or* failing him/her*, (name) of (address), or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf |
|
| November 20, 2023 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 26, 2023 at Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 26A1-26A5, East Tower, Hanwei Building No. 7 Guanghua Road, Chaoyang District Beijing 100013 Peopl |
|
| November 20, 2023 |
Concord Medical Schedules 2023 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2023 Annual Meeting of Shareholders BEIJING, November 20, 2023 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherap |
|
| September 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1 |
|
| August 17, 2023 |
Unit 2901, 29F, Tower C Beijing Yintai Centre No. 2 Jianguomenwai Avenue Chaoyang District, Beijing 100022 People’s Republic of China Phone: 86-10-6529-8300 Fax: 86-10-6529-8399 Website: www.wsgr.com 中国北京市朝阳区建国门外大街2号 银泰中心写字楼C座29层2901室 邮政编码: 100022 电话: 86-10-6529-8300 传真: 86-10-6529-8399 网站: www.wsgr.com VIA EDGAR August 17, 2023 Division of Corporation Finance Office of Industrial Applications and |
|
| July 14, 2023 |
Unit 2901, 29F, Tower C Beijing Yintai Centre No. 2 Jianguomenwai Avenue Chaoyang District, Beijing 100022 People’s Republic of China Phone: 86-10-6529-8300 Fax: 86-10-6529-8399 Website: www.wsgr.com 中国北京市朝阳区建国门外大街2号 银泰中心写字楼C座29层2901室 邮政编码: 100022 电话: 86-10-6529-8300 传真: 86-10-6529-8399 网站: www.wsgr.com VIA EDGAR July 14, 2023 Division of Corporation Finance Office of Industrial Applications and S |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 10001 |
|
| April 19, 2023 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jianyu Yang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| April 19, 2023 |
Consent of Shandong Haoxin Certified Accountants Co., Ltd. Exhibit 15.1 CONSENT OF Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 19, 2023, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited incl |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 19, 2023 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Boxun Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| April 19, 2023 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Boxun Zhang, Chief Financial Officer of t |
|
| April 19, 2023 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of t |
|
| November 25, 2022 |
Concord Medical Services Holdings Limited (the “Company”) Exhibit 99.3 Concord Medical Services Holdings Limited (the ?Company?) PROXY I/We* (name) of (address), the holder of (number) Class A ordinary shares and (number) Class B ordinary shares in the Company, hereby appoint (name) of (address) and/or* failing him/her*, (name) of (address), or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf at the |
|
| November 25, 2022 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the ?Meeting?) will be held on December 30, 2022 at 27/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| November 25, 2022 |
Concord Medical Schedules 2022 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2022 Annual Meeting of Shareholders BEIJING, November 25, 2022 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherap |
|
| November 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 10 |
|
| September 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1 |
|
| September 30, 2022 |
Concord Medical Announces Changes in Management Exhibit 99.1 Concord Medical Announces Changes in Management BEIJING, September 30, 2022 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnos |
|
| September 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1 |
|
| September 23, 2022 |
Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets (in thousands) Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2022 BEIJING, September 23, 2022 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of rad |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| June 1, 2022 |
Exhibit 99.1 Concord Medical Announces Its Subsidiary?s Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited BEIJING, June 1, 2022 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer |
|
| April 29, 2022 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes - Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer o |
|
| April 29, 2022 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yaw Kong Yap, certify that: 1. I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| April 29, 2022 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Concord Medical Services Holdings Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of t |
|
| April 29, 2022 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.1 ? Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ? I, Jianyu Yang, certify that: ? 1.I have reviewed this annual report on Form 20-F of Concord Medical Services Holdings Limited; ? 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make t |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 29, 2022 |
Consent of Shandong Haoxin Certified Accountants Co., Ltd. Exhibit 15.1 CONSENT OF Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 29, 2022, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited incl |
|
| December 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 10 |
|
| December 10, 2021 |
Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets (in thousands) Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2021 BEIJING, December 10, 2021 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and |
|
| November 29, 2021 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the ?Meeting?) will be held on December 29, 2021 at 27/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| November 29, 2021 |
Concord Medical Services Holdings Limited (the “Company”) Exhibit 99.3 Concord Medical Services Holdings Limited (the ?Company?) PROXY I/We* (name) of (address), the holder of (number) Class A ordinary shares and (number) Class B ordinary shares in the Company, hereby appoint (name) of (address) and/or* failing him/her*, (name) of (address), or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf at the |
|
| November 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 10 |
|
| November 29, 2021 |
Concord Medical Schedules 2020 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2020 Annual Meeting of Shareholders BEIJING, November 29, 2021/PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnosti |
|
| October 15, 2021 |
Consent of Shandong Haoxin Certified Accountants Co., Ltd. Exhibit 15.1 CONSENT OF Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated October 15, 2021, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited in |
|
| October 15, 2021 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 ? Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 ? In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the ?Company?) for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Jianyu Yang, Chief Executive Officer of t |
|
| October 15, 2021 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 ? Exhibit 12.1 ? Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 ? I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the ?Company?), certify that: ? 1. I have reviewed this annual report on Form 20-F of the Company; ? 2. Based on my knowledge, this annual report does not contain any untrue statement of a mat |
|
| October 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 15, 2021 |
Exhibit 15.3 October 15, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 To whom it may concern: We have read Item 16F of Form 20-F dated October 15, 2021, of Concord Medical Services Holdings Limited and are in agreement with the statements with reference to us therein. We agree with the statements concerning our Firm contained therein. /s/ Shandong Haoxin Certifie |
|
| October 15, 2021 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 ? Exhibit 12.2 ? Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 ? I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the ?Company?), certify that: ? 1. I have reviewed this annual report on Form 20-F of the Company; ? 2. Based on my knowledge, this annual report does not contain any untrue statement of a ma |
|
| October 15, 2021 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 ? Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 ? In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the ?Company?) for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Yaw Kong Yap, Chief Financial Officer of |
|
| October 15, 2021 |
Exhibit 15.2 October 15, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 16F of Form 20-F dated October 15, 2021, of Concord Medical Services Holdings Limited and are in agreement with the statements contained in the first to fourth paragraphs with reference to us therein. We have no basis to agree or disagree with other state |
|
| August 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| August 23, 2021 |
Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors Exhibit 99.1 Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors BEIJING, August 23, 2021 - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive netw |
|
| August 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| May 25, 2021 |
Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report Exhibit 99.1 Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report BEIJING, May 25, 2021 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalo |
|
| May 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1 |
|
| May 21, 2021 |
Concord Medical Announces Changes in Board of Directors Exhibit 99.1 Concord Medical Announces Changes in Board of Directors BEIJING, May 21, 2021 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging |
|
| May 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| April 30, 2021 |
SEC FILE NUMBER: 001-34563 CUSIP NUMBER: 206277 105 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 16, 2021 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to ordinary share |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 —————————————— SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| December 29, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2020 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 Peo |
|
| December 29, 2020 |
Concord Medical Announces Divestment of Singapore Concord International Hospital Exhibit 99.1 Concord Medical Announces Divestment of Singapore Concord International Hospital BEIJING, December 28, 2020 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiot |
|
| November 20, 2020 |
Concord Medical Schedules 2020 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2020 Annual Meeting of Shareholders BEIJING, November 20, 2020 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnost |
|
| November 20, 2020 |
Concord Medical Services Holdings Limited (the “Company”) P R O X Y Exhibit 99.3 Concord Medical Services Holdings Limited (the “Company”) P R O X Y I/We* ..................................................... (name) of ............................................................. (address), the holder of ..................................... (number) Class A ordinary shares and (number) Class B ordinary shares in the Company, hereby appoint ....................... |
|
| November 20, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 20, 2020 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 21, 2020 at 27/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| August 26, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2020 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| August 26, 2020 |
Concord Medical Reports Financial Results for the First Half of 2020 Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2020 BEIJING, August 26, 2020 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and dia |
|
| April 30, 2020 |
Consent of Ernst & Young Hua Ming LLP Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 30, 2020, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited and |
|
| April 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities E |
|
| April 30, 2020 |
Exhibit 2.4 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) Concord Medical Services Holdings Limited (the “Company”) is an Cayman Islands exempted company with limited liability and its affairs are governed by its memorandum and articles of association, as amended and restated from time to time, and the Comp |
|
| April 30, 2020 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fac |
|
| April 30, 2020 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer of the |
|
| April 30, 2020 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact |
|
| April 30, 2020 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of the C |
|
| March 11, 2020 |
Concord Medical Welcomes RMB700 Million Investment Exhibit 99.1 Concord Medical Welcomes RMB700 Million Investment BEIJING, March 11, 2020 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic |
|
| March 11, 2020 |
CCM / Concord Medical Services Holdings Ltd. 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| December 2, 2019 |
Concord Medical Announces Changes to the Board Exhibit 99.1 Concord Medical Announces Changes to the Board BEIJING, December 2, 2019 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced the resignation of Mr. Shang Yan Chuang as director of the Compan |
|
| December 2, 2019 |
CCM / Concord Medical Services Holdings Ltd. 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2019 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 29, 2019 |
Concord Medical Schedules 2019 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2019 Annual Meeting of Shareholders BEIJING, November 28, 2019 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2019 annual general meeting |
|
| November 29, 2019 |
CCM / Concord Medical Services Holdings Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2019 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 29, 2019 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 27, 2019 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| November 29, 2019 |
Concord Medical Services Holdings Limited (the “Company”) P R O X Y Exhibit 99.3 Concord Medical Services Holdings Limited (the “Company”) P R O X Y I/We* ............................................................... (name) of ........................................................................................................................ (address), the holder of ............................................................ (number) Class A ordinary shares |
|
| August 26, 2019 |
CCM / Concord Medical Services Holdings Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2019 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 Peopl |
|
| August 26, 2019 |
Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets (in thousands) Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2019 BEIJING, August 23, 2019 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results |
|
| April 30, 2019 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fac |
|
| April 30, 2019 |
CCM / Concord Medical Services Holdings Ltd. 20-F 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities E |
|
| April 30, 2019 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of the C |
|
| April 30, 2019 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact |
|
| April 30, 2019 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer of the |
|
| April 30, 2019 |
Consent of Ernst & Young Hua Ming LLP EX-15.1 7 tv518902ex15-1.htm EXHIBIT 15.1 Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 30, 2019, with respect to the consolidated financial statements of Conc |
|
| March 19, 2019 |
CCM / Concord Medical Services Holdings Ltd. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2019 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| March 19, 2019 |
Concord Medical Announces New Appointments to Management Team Exhibit 99.1 Concord Medical Announces New Appointments to Management Team BEIJING, March 19, 2019 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced three new appointments |
|
| March 19, 2019 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Concord Medical Services Holdings Limited (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) 206277 1051 (CUSIP Number) Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring Road East Dongcheng District, Beijing 100013 Pe |
|
| March 19, 2019 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| March 19, 2019 |
CCM / Concord Medical Services Holdings Ltd. / Zhang Bi - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Concord Medical Services Holdings Limited (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) 206277 1051 (CUSIP Number) Bi Zhang Jianyu Yang 18/F, Tower A, Global Trade Center 36 North Third Ring Road East Dongcheng District, Beijing 1 |
|
| March 19, 2019 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| February 14, 2019 |
CCM / Concord Medical Services Holdings Ltd. / Zhou Hao - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 —————————————— SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 16, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CONCORD MEDICAL SERVICES HOLDINGS LIMITED (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) SZE Mei Ming With a copy to: Fosun International Limited Gregory Wang, Esq. Room 808 Reed Sm |
|
| January 16, 2019 |
Exhibit 99.2 Fosun International Limited Name Business Address Present Principal Employment Citizenship Guo Guangchang Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong Executive Director and Chairman of Fosun International China Wang Qunbin Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong Executive Director and Chief Executive Officer of Fosun International China Chen Qiyu Room 808, |
|
| December 7, 2018 |
Concord Medical Services Holdings Limited (the “Company”) P R O X Y Exhibit 99.3 Concord Medical Services Holdings Limited (the “Company”) P R O X Y I/We* ....................................... (name) of ........................................................................................................ (address) the holder of ............... (number) shares in the Company hereby appoint ...................................... (name) of ....................... |
|
| December 7, 2018 |
CCM / Concord Medical Services Holdings Ltd. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2018 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| December 7, 2018 |
Concord Medical Schedules 2018 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2018 Annual Meeting of Shareholders BEIJING, December 7, 2018 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading cancer hospital operations management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2018 |
|
| December 7, 2018 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 29, 2018 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for share |
|
| August 30, 2018 |
Concord Medical Reports Financial Results for the First Half of 2018 Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2018 BEIJING, Aug 29, 2018 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading cancer hospital operations management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolida |
|
| August 30, 2018 |
CCM / Concord Medical Services Holdings Ltd. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2018 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| April 30, 2018 |
CFO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fac |
|
| April 30, 2018 |
CFO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer of the |
|
| April 30, 2018 |
CEO Certification Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jianyu Yang, Chief Executive Officer of the C |
|
| April 30, 2018 |
CCM / Concord Medical Services Holdings Ltd. 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2017 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities E |
|
| April 30, 2018 |
Consent of Ernst & Young Hua Ming LLP Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 30, 2018, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited and |
|
| April 30, 2018 |
CEO Certification Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact |
|
| April 4, 2018 |
Concord Medical Welcomes Investment Led by China International Capital Corporation Limited Exhibit 99.1 Concord Medical Welcomes Investment Led by China International Capital Corporation Limited BEIJING, Apr 3, 2018 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China, today announced that inves |
|
| April 4, 2018 |
CCM / Concord Medical Services Holdings Ltd. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| February 13, 2018 |
CCM / Concord Medical Services Holdings Ltd. / Carlyle Group L.P. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Concord Medical Services Holdings Limited (Name of Issuer) Ordinary shares (Title of Class of Securities) 206277105 (CUSIP Number) December 31, 2017 (Date of Event which Requires filing of this Statement) Check the appropriate box to designate t |
|
| January 16, 2018 |
Exhibit 4.1 CONCORD MEDICAL SERVICES HOLDINGS Limited 2008 SHARE INCENTIVE PLAN 1. Purpose of the Plan The purpose of the Plan is to aid the Company and its Affiliates in recruiting and retaining key employees, directors or consultants of outstanding ability and to motivate such employees, directors or consultants to exert their best efforts on behalf of the Company and its Affiliates by providing |
|
| January 16, 2018 |
CCM / Concord Medical Services Holdings Ltd. FORM S-8 As filed with the Securities and Exchange Commission on January 16, 2018 Registration No. |
|
| December 21, 2017 |
Concord Medical Holds 2017 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Holds 2017 Annual Meeting of Shareholders BEIJING, December 21, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it held its 2017 annual |
|
| December 21, 2017 |
CCM / Concord Medical Services Holdings Ltd. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2017 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 28, 2017 |
Concord Medical Services Holdings Limited (the "Company") Exhibit 99.2 Concord Medical Services Holdings Limited (the "Company") NOTICE OF Annual GENERAL MEETING NOTICE is hereby given that an Annual General Meeting of the Company will be held on December 21, 2017 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 AM (Beijing time) for the purposes of considering and, if thought fit, passi |
|
| November 28, 2017 |
Concord Medical Schedules 2017 Annual Meeting of Shareholders Exhibit 99.1 Concord Medical Schedules 2017 Annual Meeting of Shareholders BEIJING, November 16, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 20 |
|
| November 28, 2017 |
Concord Medical Services Holdings Limited (the "Company") SHAREHOLDER PROXY Exhibit 99.3 Concord Medical Services Holdings Limited (the "Company") SHAREHOLDER PROXY I/We, of , being the registered holder(s) of (Note 1) class (Note 1) ordinary share(s) of the Company, hereby appoint the Chairman of the Meeting or (Note 2) of as my/our proxy to act for me/us at the annual general meeting of the Company to be held at 10:00 a.m. on December 21, 2017 at 18/F, Tower A, Global T |
|
| November 28, 2017 |
CCM / Concord Medical Services Holdings Ltd. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2017 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 14, 2017 |
CCM / Concord Medical Services Holdings Ltd. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2017 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 1000 |
|
| November 14, 2017 |
Concord Medical Announces Withdrawal of Buyer Parties’ Going Private Proposal Exhibit 99.1 Concord Medical Announces Withdrawal of Buyer Parties? Going Private Proposal BEIJING, November 13, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its |
|
| November 14, 2017 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Concord Medical Services Holdings Limited (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) Jianyu Yang Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring R |
|
| November 14, 2017 |
Exhibit 99.2 November 13, 2017 The Board of Directors Concord Medical Services Holdings Limited 18/F, Tower A, Global Trade Center 36 North Third Ring Road East Dongcheng District, Beijing 100013 People’s Republic of China Dear Sirs: Re: Withdrawal of the Non-binding Proposal to Acquire All Outstanding Class A Ordinary Shares and American Depositary Shares of the Company Not Owned by the Buyer Par |
|
| November 14, 2017 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| November 13, 2017 |
Exhibit 99.3 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of 31st October 2017 by and among: (1) Oasis Inspire Limited, a company incorporated under the laws of the British Virgin Islands (the “Purchaser”); (2) Carlyle Asia Growth Partners III, L.P., an exempted limited partnership organized under the laws of the Cayman Islands acting by its |
|
| November 13, 2017 |
Exhibit 99.5 Letter of Undertaking October 31, 2017 Fosun International Limited (“Fosun International”) Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong RE: Undertaking We understand that Oasis Inspire Limited (“Oasis”) (a British Virgin Islands company) or another subsidiary or affiliate of Fosun International (Oasis or such other subsidiary or affiliate (as applicable) is hereinafter refe |
|
| November 13, 2017 |
Exhibit 99.2 Fosun International Limited Name Business Address Present Principal Employment Citizenship Guo Guangchang Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong Executive Director and Chairman of Fosun International China Wang Qunbin Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong Executive Director and Chief Executive Officer of Fosun International China Chen Qiyu Room 808, |
|
| November 13, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CONCORD MEDICAL SERVICES HOLDINGS LIMITED (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) SZE Mei Ming With a copy to: Fosun International Limited Gregory Wang, Esq. Room 808 Reed Smith |
|
| November 13, 2017 |
Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Exchange Act or any rule or regulation thereunder (including a |
|
| November 13, 2017 |
Exhibit 99.4 Letter of Undertaking October 31, 2017 RE: Undertaking The undersigned hereby undertakes to and agrees with Oasis Inspire Limited (“Oasis”) as follows: (1) Appointment of Fosun International Designee to the Board. Mr. Jianyu Yang (the “Controlling Shareholder”) of Concord Medical Services Holdings Limited (the “Company”) shall use his best efforts to (i) nominate and support the elect |
|
| September 18, 2017 |
Concord Medical Announces Changes to the Board EX-99.1 2 v475346ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Concord Medical Announces Changes to the Board BEIJING, Sept. 18, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced t |
|
| September 18, 2017 |
Concord Medical Services Holdings 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2017 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100 |
|
| August 31, 2017 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2017 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 |
|
| August 31, 2017 |
Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets (in thousands) Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2017 BEIJING, Aug 25, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolid |
|
| July 26, 2017 |
Concord Medical Announces Changes to the Board Exhibit 99.1 Concord Medical Announces Changes to the Board BEIJING, July 24, 2017 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the resignation of Mr. Zhe Yin and Ms. Yan |
|
| July 26, 2017 |
Concord Medical Services Holdings 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 People? |
|
| June 13, 2017 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3/A (Amendment No. 1) (Rule 13e-100) Transaction Statement under Section 13(e) of the Securities Exchange Act of 1934 and Rule 13e-3 thereunder Rule 13e-3 Transaction Statement under Section 13(e) of the Securities Exchange Act of 1934 CONCORD MEDICAL SERVICES HOLDINGS LIMITED (Name of Issuer) Jianyu Yang Shanghai |
|
| May 23, 2017 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| May 23, 2017 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Concord Medical Services Holdings Limited (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) Jianyu Yang Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring R |
|
| May 1, 2017 |
Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the ?Company?) for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Jianyu Yang, Chief Executive Officer of the C |
|
| May 1, 2017 |
Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the ?Company?) for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Yaw Kong Yap, Chief Financial Officer of the |
|
| May 1, 2017 |
Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the ?Company?), certify that: 1. I have reviewed this annual report of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to |
|
| May 1, 2017 |
Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the ?Company?), certify that: 1. I have reviewed this annual report of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to s |
|
| May 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2016 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities E |
|
| February 9, 2017 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SC 13E3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Rule 13e-100) Transaction Statement under Section 13(e) of the Securities Exchange Act of 1934 and Rule 13e-3 thereunder Rule 13e-3 Transaction Statement under Section 13(e) of the Securities Exchange Act of 1934 CONCORD MEDICAL SERVICES HOLDINGS LIMITED (Name of the Issuer) Jianyu Yang Shanghai Hui Fu Science |
|
| February 9, 2017 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| February 9, 2017 |
Exhibit (b)(1) Execution Version Note Subscription Agreement among Morgancreek Investment Holdings Limited and Mr. |
|
| February 9, 2017 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Concord Medical Services Holdings Limited (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) Jianyu Yang Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring R |
|
| February 9, 2017 |
Cayman Companies Law Cap. 22 (Law 3 of 1961, as consolidated and revised) – Section 238 Exhibit (f) Cayman Companies Law Cap. 22 (Law 3 of 1961, as consolidated and revised) – Section 238 238. Rights of dissenters (1) A member of a constituent company incorporated under this Law shall be entitled to payment of the fair value of his shares upon dissenting from a merger or consolidation. (2) A member who desires to exercise his entitlement under subsection (1) shall give to the constit |
|
| February 9, 2017 |
Exhibit 99.2 Execution Version Note Subscription Agreement among Morgancreek Investment Holdings Limited and Mr. Jianyu Yang and Blue Ocean Structure Investment II Company Limited and Blue Ocean Project Fund II, LP Dated February 9, 2017 Table of Contents 1. Interpretations 2 2. The Notes 10 3. Representations and Warranties 12 4. Issuer Parties’ Obligation between Execution and Issuance Date 14 5 |
|
| November 22, 2016 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| November 22, 2016 |
Exhibit 99.3 Equitable Mortgage Over Shares in Concord Medical Services Holdings Limited 22 November 2016 MORGANCREEK INVESTMENT HOLDINGS LIMITED (as Mortgagor) and Haitong International Securities Company Limited (as Mortgagee) This equitable mortgage over shares (this “Mortgage”) is made on the 22nd day of November 2016 Between: (1) MORGANCREEK INVESTMENT HOLDINGS LIMITED, a company incorporated |
|
| November 22, 2016 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Concord Medical Services Holdings Limited (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) Jianyu Yang Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring R |
|
| November 22, 2016 |
Exhibit 99.2 DATED 22 November 2016 morgancreek investment holdings limited as Chargor and Haitong International Securities Company Limited as Chargee SHARE CHARGE PROSKAUER ROSE Suites 1701-1705, 17/F Two Exchange Square 8 Connaught Place, Central Hong Kong CONTENTS PAGE CLAUSE PAGE 1. Definitions and Interpretation 1 2. Covenant to Pay 6 3. SECURITY 6 4. Restrictions and Further Assurance 6 5. C |
|
| August 25, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2016 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 Peopl |
|
| August 25, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2016 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 Peopl |
|
| August 25, 2016 |
Concord Medical Reports Financial Results for the First Half of 2016 Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2016 BEIJING, August 24, 2016 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited conso |
|
| August 25, 2016 |
Concord Medical Reports Financial Results for the First Half of 2016 Exhibit 99.1 Concord Medical Reports Financial Results for the First Half of 2016 BEIJING, August 24, 2016 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited conso |
|
| July 11, 2016 |
Concord Medical Announces Receipt of Preliminary Non-Binding “Going Private” Proposal Exhibit 99.1 Concord Medical Announces Receipt of Preliminary Non-Binding ?Going Private? Proposal BEIJING, July 11, 2016 /PRNewswire/ - Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that |
|
| July 11, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 - Commission File Number: 001-34563 - CONCORD MEDICAL SERVICES HOLDINGS LIMITED - 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 P |
|
| July 11, 2016 |
CCM / Concord Medical Services Holdings Ltd. / Cheng Zheng - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Concord Medical Services Holdings Limited (Name of Issuer) Class A ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 206277 105(1) (CUSIP Number) Jianyu Yang Zheng Cheng 18/F, Tower A, Global Trade Center 36 North Third Ring R |
|
| July 11, 2016 |
Exhibit 99.2 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 11, 2016 by and among: (1) Morgancreek Investment Holdings Limited, a limited liability company incorporated under the laws of the British Virgin Islands (the “Purchaser”); (2) Carlyle Asia Growth Partners III, L.P., an exempted limited partnership organized under the laws of |
|
| July 11, 2016 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A ordina |
|
| July 11, 2016 |
Exhibit 99.4 The Board of Directors Concord Medical Services Holdings Limited 18/F, Tower A, Global Trade Center 36 North Third Ring Road East Dongcheng District, Beijing 100013 People’s Republic of China July 11, 2016 Dear Sirs: Mr. Jianyu Yang (“Mr. Yang”), the chairman and chief executive officer of Concord Medical Services Holdings Limited (the “Company”), Morgancreek Investment Holdings Limit |
|
| July 11, 2016 |
Exhibit 99.5 MEMORANDUM OF UNDERSTANDING This MEMORANDUM OF UNDERSTANDING (“MoU”) dated July 11, 2016 is made by and among: Blue Ocean Management Limited (“Blue Ocean”); Morgancreek Investment Holdings Limited (“Morgancreek”); and Jianyu Yang (“Chairman”) Each of Blue Ocean, Morgancreek and Chairman is hereinafter referred to as a “Party” and collectively as the “Parties”. A. Morgancreek is an exi |
|
| July 11, 2016 |
Exhibit 99.3 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 11, 2016 by and among: (1) Morgancreek Investment Holdings Limited, a limited liability company incorporated under the laws of the British Virgin Islands (the “Purchaser”); (2) Solar Honor Limited, a limited liability company incorporated under the laws of the British Virgin I |
|
| May 24, 2016 |
Concord Medical Reports Financial Results for the First Quarter of 2016 Exhibit 99.1 Concord Medical Reports Financial Results for the First Quarter of 2016 BEIJING, May 24, 2016 /PRNewswire/ - Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited conso |
|
| May 24, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 People?s Rep |
|
| April 28, 2016 |
Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the ?Company?), certify that: 1. I have reviewed this annual report of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to s |
|
| April 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2015 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities E |
|
| April 28, 2016 |
Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer of the |
|
| April 28, 2016 |
Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002 I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. I have reviewed this annual report of the Company; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to |
|
| April 28, 2016 |
Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the ?Company?) for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Jianyu Yang, Chief Executive Officer of the C |
|
| March 29, 2016 |
Concord Medical Reports Fourth Quarter and Full Year 2015 Financial Results Exhibit 99.1 Concord Medical Reports Fourth Quarter and Full Year 2015 Financial Results BEIJING, March 28, 2015 /PRNewswire/ ? Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited |
|
| March 29, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 People?s R |
|
| January 27, 2016 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) Form 6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D. |
|
| January 27, 2016 |
Corrections to Certain Disclosures in the Company’s 2014 Annual Report on Form 20-F EX-99.1 Exhibit 99.1 Corrections to Certain Disclosures in the Company?s 2014 Annual Report on Form 20-F In its annual report on Form 20-F for the year ended December 31, 2014 filed with the Securities and Exchange Commission on April 27, 2015 ( the ?2014 Form 20-F?), Concord Medical Services Holdings Limited (the ?Company?) incorrectly indicated that ASU No. 2014-08 ?Presentation of Financial Sta |
|
| December 22, 2015 |
Concord Medical Services Holdings ESP Correspondence SIMPSON THACHER & BARTLETT ICBC TOWER, 35TH FLOOR 3 GARDEN ROAD HONG KONG (852) 2514-7600 FACSIMILE (852) 2869-7694 DIRECT DIAL NUMBER (852) 2514-7630 E-MAIL ADDRESS lchen@stblaw. |
|
| December 15, 2015 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) Form 6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D. |
|
| December 15, 2015 |
Concord Medical to Hold Annual General Meeting on December 31, 2015 EX-99.1 Exhibit 99.1 Concord Medical to Hold Annual General Meeting on December 31, 2015 BEIJING, December 15, 2015 /PRNewswire/ ? Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the C |
|
| December 11, 2015 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) Form 6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D. |
|
| December 11, 2015 |
Concord Medical Declares Special Dividend EX-99.1 Exhibit 99.1 Concord Medical Declares Special Dividend BEIJING, December 11, 2015 /PRNewswire/ ? Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that on December 11, 2015, its Board |
|
| November 19, 2015 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) Form 6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D. |
|
| November 19, 2015 |
Concord Medical Reports Third Quarter 2015 Financial Results EX-99.1 Exhibit 99.1 Concord Medical Reports Third Quarter 2015 Financial Results BEIJING, November 18, 2015 /PRNewswire/ ? Concord Medical Services Holdings Limited (?Concord Medical? or the ?Company?) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited con |
|
| October 19, 2015 |
EX-99.(E) 3 e614199ex99-e.htm Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Concord Medical Services Holdings Limited, 333-163559) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) T |
|
| October 19, 2015 |
J.P. Morgan J.P. Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 2 (d) Custodian 2 (e) Deliver, execute, issue et al. 2 (f) Delivery Order 2 (g) Deposited Securities 2 (h) Direct Registration System 2 (i) Holder 2 (j) Securities Act of 1933 2 (k) Securities Exchange Act of 1934 2 (l) Shares 3 (m) Tran |
|
| October 19, 2015 |
As filed with the U.S. Securities and Exchange Commission on October 19, 2015 As filed with the U.S. Securities and Exchange Commission on October 19, 2015 Registration No. 333- 163559 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ForAmerican Depositary Shares Evidenced by American Depositary Receipts Concord Medical Services Holdings Limited (Exact name of issuer |
|
| September 9, 2015 |
Concord Medical Services Holdings FORM 6-K (Current Report of Foreign Issuer) Form 6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D. |
|
| September 9, 2015 |
EX-99.1 2 d56231dex991.htm EX-99.1 Exhibit 99.1 Concord Medical Announces Plan to Establish Beijing Allcure Medical Information Technology Ltd and Management Team Change BEIJING, Sept. 8, 2015 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of rad |
